Midterm outcomes in patients with intermediate‐sized hepatocellular carcinoma

Abstract

In patients with intermediate-sized HCCs, RFA combined with TACE is more effective than RFA alone for extending the ablated area in fewer treatment sessions and for decreasing the local tumor progression rate.